Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | Department of Health and Social Care (DHSC) |
| Main Category: | Services |
| Procurement Method: | Single tender action (below threshold) |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
11 November 2024
Closed
Estimated Value
£127,400
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £127,400 |
| Release Date: | 22 November 2024 |
| Application Deadline: | 11 November 2024 |
| Contract Start Date: | 1 December 2024 |
| Contract End Date: | 31 July 2025 |
| Contract Duration: | 8 months |
| Procurement ID (OCID): | ocds-b5fd17-d2b036a8-248a-4535-960a-f24decb24608 |
| Notice Reference: | 82a955ca-316b-4423-9f10-43608918cc60-805141 |
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £152,880 |
| Award decision date: | 22 November 2024 |
| Award status: | Active |
The second phase of work on the prostate cancer cost-effectiveness model will build on the initial efforts update a suitable prostate cancer cost effectiveness model, focusing on further evaluation and development of the model to influence screening programmes. To evaluate the cost-effectiveness of PSA-based screening for all men aged 45-70- and 45-75-year-old, with the frequency of testing stratified by individual risk calculated from an initial PSA, age, ethnicity, and family history (e.g., initially yearly for high-risk and 3-5 yearly for low-risk men). To evaluate the cost-effectiveness of prostate cancer screening programmes for men between the age of 50-69 years with a Charlson Comorbidity Index (≤3) using the Stockholm3 blood test. The delivery will also explore: • a screening programme for prostate cancer for men aged 45-70 who have a first-degree rela-tive diagnosed with prostate, breast or ovarian cancer (relevant family history) • a screening programme in black men aged 45 - 70 • a screening programme in BRCA2 carriers The prostate cancer screening model developed and owned by the University of Sheffield was deemed the most independent and suitable option for achieving the project's deliverables. Contract value: £127,400 exclusive of VAT. £152,880 inclusive of VAT Term: 7 months up to 31/072025 with the option to extend for up to 6 months to the discretion of the authority.
Published contracts in the last 12 months
65
total contracts
£38.9m
total value
£597,932
average contract size
Typical categories
Request for Information - Ambulance Radio Programme (ARP) Network Infrastructure Services
Department of Health and Social Care (DHSC) · WAC-353051
Request for Information - Ambulance Radio Programme (ARP) Network Infrastructure Services
Department of Health and Social Care (DHSC) · WAC-353394
Request for Information - Ambulance Radio Programme (ARP) Network Infrastructure Services
Department of Health and Social Care (DHSC) · WAC-353401